|
Name |
Anthracobic acid B
|
Molecular Formula | C25H32O4 | |
IUPAC Name* |
(2E,4E,6Z,8E)-9-[(1aS,2S,3aR,7aR,7bS)-2-[(E)-but-2-en-2-yl]-2-hydroxy-6-methyl-3,3a,4,7,7a,7b-hexahydro-1aH-naphtho[1,2-b]oxiren-3-yl]-6-methylnona-2,4,6,8-tetraenoic acid
|
|
SMILES |
C/C=C(\C)/[C@@]1([C@@H]2[C@@H](O2)[C@@H]3CC(=CC[C@H]3C1/C=C/C=C(/C)\C=C\C=C\C(=O)O)C)O
|
|
InChI |
InChI=1S/C25H32O4/c1-5-18(4)25(28)21(11-8-10-16(2)9-6-7-12-22(26)27)19-14-13-17(3)15-20(19)23-24(25)29-23/h5-13,19-21,23-24,28H,14-15H2,1-4H3,(H,26,27)/b9-6+,11-8+,12-7+,16-10-,18-5+/t19-,20-,21?,23+,24+,25-/m1/s1
|
|
InChIKey |
RFLQWGOTYZWRJB-WSWMBLLHSA-N
|
|
Synonyms |
Anthracobic acid B
|
|
CAS | NA | |
PubChem CID | 139588835 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 396.5 | ALogp: | 4.6 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 70.1 | Aromatic Rings: | 3 |
Heavy Atoms: | 29 | QED Weighted: | 0.281 |
Caco-2 Permeability: | -4.778 | MDCK Permeability: | 0.00000880 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.026 | 20% Bioavailability (F20%): | 0.059 |
30% Bioavailability (F30%): | 0.344 |
Blood-Brain-Barrier Penetration (BBB): | 0.23 | Plasma Protein Binding (PPB): | 92.46% |
Volume Distribution (VD): | 0.441 | Fu: | 8.98% |
CYP1A2-inhibitor: | 0.441 | CYP1A2-substrate: | 0.12 |
CYP2C19-inhibitor: | 0.183 | CYP2C19-substrate: | 0.108 |
CYP2C9-inhibitor: | 0.53 | CYP2C9-substrate: | 0.981 |
CYP2D6-inhibitor: | 0.825 | CYP2D6-substrate: | 0.864 |
CYP3A4-inhibitor: | 0.672 | CYP3A4-substrate: | 0.127 |
Clearance (CL): | 1.488 | Half-life (T1/2): | 0.094 |
hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.962 |
Drug-inuced Liver Injury (DILI): | 0.958 | AMES Toxicity: | 0.261 |
Rat Oral Acute Toxicity: | 0.601 | Maximum Recommended Daily Dose: | 0.949 |
Skin Sensitization: | 0.737 | Carcinogencity: | 0.464 |
Eye Corrosion: | 0.019 | Eye Irritation: | 0.045 |
Respiratory Toxicity: | 0.964 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003585 | 1.000 | D0G3PI | 0.311 | ||||
ENC002015 | 0.343 | D00DKK | 0.311 | ||||
ENC001936 | 0.314 | D02DGU | 0.311 | ||||
ENC005165 | 0.314 | D0FG6M | 0.295 | ||||
ENC005164 | 0.314 | D05QDC | 0.274 | ||||
ENC002157 | 0.301 | D0S7WX | 0.257 | ||||
ENC003852 | 0.300 | D0B1IP | 0.230 | ||||
ENC004753 | 0.280 | D0MY8N | 0.203 | ||||
ENC003854 | 0.279 | D0B4RU | 0.190 | ||||
ENC003853 | 0.279 | D0E9KA | 0.182 |